InfuSystem Valuation Multiples

InfuSystem Overview

About InfuSystem

InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.

Founded

2005

HQ

Employees

514

Website

infusystem.com

Sectors

Medical DevicesDeepTechHealthTech

Financials (LTM)

Revenue: $144M

EBITDA: $32M

EV

$208M

Valuation Multiples

Multiples.vc

Start free trial

InfuSystem Financials

InfuSystem reported last 12-month revenue of $144M and EBITDA of $32M.

In the same LTM period, InfuSystem generated $81M in gross profit, $32M in EBITDA, and $7M in net income.

InfuSystem P&L

In the most recent fiscal year, InfuSystem reported revenue of $143M and EBITDA of $31M.

InfuSystem expects next 12-month revenue of XXX and NTM EBITDA of XXX

InfuSystem Stock Performance

InfuSystem has current market cap of $188M, and enterprise value of $208M.

InfuSystem's stock price is $9.29.

InfuSystem Valuation Multiples

InfuSystem trades at 1.4x EV/Revenue multiple, and 6.5x EV/EBITDA.

InfuSystem Financial Valuation Multiples

As of April 3, 2026, InfuSystem has market cap of $188M and EV of $208M.

Equity research analysts estimate InfuSystem's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

InfuSystem has a P/E ratio of 26.1x.

InfuSystem Margins & Growth Rates

InfuSystem's revenue in the last 12 month grew by 3%.

InfuSystem's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.

InfuSystem's rule of 40 is 24% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

InfuSystem's rule of X is 26% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

InfuSystem Public Comps

See public comps and valuation multiples for other Medical Devices comps.

InfuSystem M&A Activity

InfuSystem acquired XXX companies to date.

Last acquisition by InfuSystem was on XXXXXXXX, XXXXX. InfuSystem acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

InfuSystem Investment Activity

InfuSystem invested in XXX companies to date.

InfuSystem made its latest investment on XXXXXXXX, XXXXX. InfuSystem invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).